INNOVATION IN CNS DRUG DISCOVERY: FROM SMALL MOLECULES TO BIOLOGIC THERAPIES
|
|
|
- Lucas Wilson
- 8 years ago
- Views:
Transcription
1 INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (11) Undicesima Scuola Estiva di Neuroscienze (11) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL SOCIETIES (EPHAR) THE ITALIAN SOCIETY OF PHARMACOLOGY (SIF) AND THE ITALIAN SOCIETY OF NEUROPSYCHOPHARMACOLOGY (SINPF) July 6-12, 2013 INNOVATION IN CNS DRUG DISCOVERY: FROM SMALL MOLECULES TO BIOLOGIC THERAPIES Catania Aula Magna Palazzo Centrale dell Università Piazza Università, 2
2 Chairman Filippo Drago (Catania) Scientific Secretariat Filippo Caraci (Catania) Scientific Committee Eugenio Aguglia (Catania) Claudio Bucolo (Catania) Pier Luigi Canonico (Novara) Donatella Marazziti (Pisa) Giancarlo Pepeu (Florence) Giorgio Racagni (Milan) Salvatore Salomone (Catania) Maria Angela Sortino (Catania)
3 Saturday July 6 th, Registration Opening remarks Filippo Drago (Catania) Opening lecture (introduced by Filippo Drago) Innovation in neuroscience: which implications for CNS drug research? Siegfried Kasper (Austria) Welcome reception Innovation in CNS drug discovery: general principles Introduced and moderated by Mariano Malaguarnera (Italy) Role of neuroimaging in CNS drug discovery Richard G. Wise (United Kingdom) Genomics and pharmacogenomics of brain disorders: implications for CNS drug research Ramon Cacabelos (Spain) Clinical trials design for disease-modifying drugs: the role of biological markers Daniela Galimberti (Italy)
4 Sunday July 7 th, 2013 CNS disorders in childhood: new targets and new drugs Introduced and moderated by Salvatore Salomone (Italy) Pathways to drug development for autism spectrum disorders Kathryn Chadman (USA) New pharmacological approaches to neurocutaneuos disorders Martino Ruggieri (Italy) Discussion Sponsored lecture by Biogen Idec New Perspectives for MS Treatment: focus on BG-12 mechanism of action Ralf Gold (Germany) Multiple sclerosis Introduced and moderated by Giorgio Racagni (Italy) Immunomodulatory treatment strategies in multiple sclerosis Ferdinando Nicoletti (Italy) Neuroprotection and repair in multiple sclerosis Rina Aharoni (Israel) Special Lecture: Novel drugs for the treatment of multiple sclerosis: from biologic to small molecules? Giancarlo Comi (Italy)
5 Monday July 8 th, 2013 Schizophrenia Introduced and moderated by Eugenio Aguglia (Italy) Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap Neil Dawson (United Kingdom) Novel antipsychotic drugs for schizophrenia Edoardo Spina (Messina) Discussion Sponsored lecture by Zambon Group Glutamate-dopamine interaction in the pathogenesis of Parkinson s disease: new targets for the treatment Paolo Barone (Italy) Depression Introduced and moderated by Donatella Marazziti (Italy) Antistress properties of antidepressant drugs and their clinical implications Marco Riva (Italy) The cytokine hypothesis of depression: new targets for adjunctive treatments in depression Nicoletta Brunello (Italy) Discussion Special Lecture: Emerging therapies for depression Ronald Duman (USA)
6 Tuesday July 9 th, 2013 Neurodegenerative disorders Introduced and moderated by Maria Angela Sortino (Italy) The kynurenine pathway in neurodegenerative disorders Francesca M. Notarangelo (USA) Cell therapies for ischemic stroke - are we ready for clinical translations? Johannes Boltze (Germany) Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis Francesco Fornai (Italy) ,30 Discussion Alzheimer s disease Introduced and moderated by Giancarlo Pepeu (Italy) Target identification for drug discovery in AD Monica Di Luca (Italy) Neuroinflammation in AD: perspectives for drug development Claudio Cuello (Canada) Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Cynthia A. Lemere (USA)
7 Wednesday July 10 th, 2013 Drug discovery in ocular pharmacology Introduced and moderated by Claudio Bucolo(Italy) Retinal neuroprotection: novel pharmacological targets Rossella Russo (Italy) Neuroprotection in glaucoma M. Francesca Cordeiro (United Kingdom) Discussion Parkinson s disease Introduced and moderated by Pier Luigi Canonico (Italy) Drug discovery in PD: evidence from animal models David T. Dexter (United Kingdom) Pharmacological treatment of Parkinson s disease: current options and new avenues Mario Zappia (Italy) Neuroprotection in PD Miquel Vila (Spain)
8 Thursday July 11 th, 2013 Epilepsy Introduced and moderated by Carmela Parenti (Italy) New horizons in the development of antiepileptic drugs: the search for new targets Anna Maria Vezzani (Italy) Novel drugs for epilepsy Emilio Perucca (Italy) Discussion Chronic Pain Syndromes Introduced and moderated by Fabio Tascedda (Italy) New strategies for target identification in chronic pain Santina Chiechio (Italy) Peripheral mechanisms of pain and analgesia: implications for drug development Cristophe Stein (Germany) Neuropathic pain: diagnosis, pathophysiological mechanisms and treatment Ralf Baron (Germany)
9 Friday July 12 th, 2013 Innovation in CNS drug discovery: from small molecules to biologic therapies Introduced and moderated by Filippo Caraci (Italy) Can we vaccinate against affective disorders? Stefan Reber (Germany) Monoclonal antibodies as novel neurotherapeutic agents in CNS injury and repair Hari Shankar Sharma (Sweden) Discussion Sponsored lecture by Roche Glutamatergic system as a new target for the treatment of negative symptoms in schizophrenia Ferdinando Nicoletti (Italy) Closing remarks Filippo Drago (Catania) Questionnaire
NEUROINFLAMMATION IN CNS DISORDERS: PRIMING A TARGET FOR NEW THERAPIES
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (10) Decima scuola estiva di Neuroscienze (10) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
PARKINSON S DISEASE MULTIPLE DOMAINS
PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (5) Quinta scuola estiva di Neuroscienze (5) July 7-13, 2007 PARKINSON S DISEASE MULTIPLE DOMAINS Catania Parco degli
Academic Calendar for Faculty
Summer 2013 Term June 3, 2013 (Monday) June 3-4, 2013 (Monday Tuesday) June 5, 2013 (Wednesday) June 5-6, 2013 (Wednesday Thursday) June 6, 2013 (Thursday) July 3, 2013 (Wednesday) July 4, 2013 (Thursday)
MS: from disease management to patient management
2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain 18-19 May 2012 Dear Colleague On behalf of the Serono Symposia International Foundation we
5 February 2016 - Bari, Italy
Updates on MS treatment management 5 February 2016 - Bari, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
ONWAR. 9th GRADUATE COURSE ON NEUROPSYCHOPHARMACOLOGY SEPTEMBER 3-10, 2015
ONWAR 9th GRADUATE COURSE ON NEUROPSYCHOPHARMACOLOGY SEPTEMBER 3-10, 2015 1 PREFACE This 9 th graduate Neuropsychopharmacology course, designed for PhD students and postdocs in the field of neurosciences,
NEUROSCIENCE. THE POWER OFxTM. Experts. Experience. Execution. Medpace Neuroscience Expertise. medpace.com
THE POWER OFxTM Experts. Experience. Execution. Medpace Neuroscience Expertise As a best-in-class strategic partner for sponsors in neuroscience drug and device development, Medpace utilizes key industry
FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES
FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES Siena, November 4-5, 2004 AUSPICES SIE SIES University of Siena Department of Medicine and Immunological Sciences Section of Hematology and Transplantion,
placebo-controlledcontrolled double-blind, blind,
Clinical Potential of Minocycline for Depression with Psychotic Features Tsuyoshi Miyaoka Department of Psychiatry Shimane University School of Medicine Minocycline 1. Second-generation tetracycline which
MATCHDAY 1 7-9 September 2014
MATCHDAY 1 7-9 September 2014 7 September Sunday 18:00 Group D 7 September Sunday 20:45 Group D 7 September Sunday 20:45 Group D 7 September Sunday 18:00 Group F 7 September Sunday 20:45 Group F 7 September
FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE. Porto Pirgos Hotel (www.portopirgos.com), Parghelia (VV), Calabria, Italy
FIRST INTERNATIONAL PORTO PIRGOS CONFERENCE ON ADVANCES IN NEUROSCIENCE Porto Pirgos Hotel (www.portopirgos.com), Parghelia (VV), Calabria, Italy 22-25 September, 2004 Under the Auspices of the Calabria
Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW EFFICACY IN PEOPLE WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN LARGE PHASE III STUDY
NEWS RELEASE Media Contact: Tara Iannuccillo (650) 467-6800 Investor Contacts: Stefan Foser Karl Mahler (650) 467-2016 011 41 61 687 8503 GENENTECH S OCRELIZUMAB FIRST INVESTIGATIONAL MEDICINE TO SHOW
American College of Allergy, Asthma & Clinical Immunology (ACAAI), USA International Center for Interdisciplinary Studies of Immunology Washington
3 rd International Symposium: New Horizons in Treatment Modalities for Allergic & Immunologic Diseases SCIENTIFIC PROGRAM October 3-4, 2008 NH Laguna Palace, Mestre Venice, Italy Organized in cooperation
29 January 2016 - Rome, Italy
Updates on MS treatment management 29 January 2016 - Rome, Italy Aims The multiple sclerosis (MS) treatment scenario is rapidly changing. New drugs are now or will be soon at disposal of clinicians allowing
11 E.M.R.S.S. COURSE
11 COURSE THE ROLE OF FUNCTIONAL ASSESSMENT AND REHABILITATION IN PARKINSON'S DISEASE AND PARKINSONISMS Syracuse 09th 12th November 2015 President Francesco Cirillo Scientific Committee: Paolo Boldrini,
October 13, 2014. Signature Programs
Signature Programs October 13, 2014 Neuroscience The goal of the neuroscience initiative is to create a nationally recognized center of research into the biological bases of brain function and dysfunction
Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV
Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute
How To Understand And Treat Pain In Neurobiological Conditions
INTERNATIONAL WORKSHOP CHRONIC PAIN IN NEUROREHABILITATION AN UPDATE OF THE ITALIAN CONSENSUS CONFERENCE IRCCS FONDAZIONE SANTA LUCIA AUDITORIUM ROME CHAIRMEN MARIA GABRIELLA BUZZI - GIORGIO CRUCCU - GIORGIO
International Symposium on: Pain and Cough
International Symposium on: Pain and Cough Florence (Italy), March 19-21, 2015 Organized by DEPARTMENT OF HEALTH SCIENCES DEPARTMENT OF EXPERIMENTAL AND CLINICAL MEDICINE UNIVERSITY OF FLORENCE DEPARTMENT
13 September 2016 - London, UK
INTERNATIONAL WORKSHOP PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 13 September 2016 - London, UK MS Academia - Multiple sclerosis advanced course Overview Multiple sclerosis
New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel
New Frontiers in Glaucoma Management Rome, 7 February 2014 Donna Camilla Savelli Hotel FACULTY Marco Centofanti University of Rome Tor Vergata Head of Glaucoma Research Line IRCCS - Fondazione Bietti Rome
SAPIENZA UNIVERSITA DI ROMA UNIVERSITY OF CALIFORNIA SAN DIEGO FIRST ANNUAL CONFERENCE ON TRANSLATIONAL RESEARCH IN MEDICINE
SAPIENZA UNIVERSITA DI ROMA UNIVERSITY OF CALIFORNIA SAN DIEGO FIRST ANNUAL CONFERENCE ON TRANSLATIONAL RESEARCH IN MEDICINE May 7-9, 2009 Sant Andrea Hospital, Rome Dear Colleagues, The First Annual Conference
Monday, August 25, 2014
Danish Dementia Research Centre, Copenhagen University Kristian Steen Frederiksen, MD, PhD; Danish Dementia Research Centre, Copenhagen University Danish Dementia Research Centre, Copenhagen University
MOOD & BRAIN: Molecular Markers, Neuroimaging, and Cognitive Neuroscience
Canadian Network for Mood and Anxiety Treatments MOOD & BRAIN: Molecular Markers, Neuroimaging, and Cognitive Neuroscience January 24-25, 2014 Sheraton Centre Toronto 123 Queen Street West Toronto, ON
Neurological Disorders Summit
Neurological Disorders Summit July 2015 06-08 San Francisco USA Welcome Message United Scientific Group takes great pleasure in inviting you to participate at the Neurological Disorders Summit (), July
DoubleTree by Hilton Hotel Zagreb, Ulica Grada Vukovara 269a, Zagreb, Croatia
March 5 7, 2015 DoubleTree by Hilton Hotel Zagreb, Ulica Grada Vukovara 269a, Zagreb, Croatia Organizers: MS Research Association Croatia Referral Centre for Demyelinating Diseases of the CNS, Department
2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives
Descriptions and Neuroplasticity Health care providers are facing greater time restrictions to render services to the individual with neurological dysfunction. However, the scientific community has recognized
Regional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015
LS LS Magna Gr ae cia University of Catanzaro, Italy Preliminary Program PhD PROGRAMME PhD PROGRAMME MOLECULAR AND TRANSLATIONAL ONCOLOGY LIFE SCIENCES ORGANIZING COMMITTEE Professor Ennio Carbone Head
IPMSC First Scientific Conference Daily Program
IPMSC First Scientific Conference Daily Program February 6 th 2013 19:30 Welcome dinner at the NH Milano 2 Hotel February 7 th 2013 Meeting Venue: San Raffaele Congress Centre - Caravella Santa Maria Room
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
CDRD and the MSSC Seek Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis
CDRD and the MSSC Seek Collaborative Projects to Discover and Develop New Treatments for Progressive Multiple Sclerosis The Centre for Drug Research and Development (CDRD) and the Multiple Sclerosis Society
PREDICTION AND PREVENTION OF DEMENTIA: NEW HOPE SECOND INTERNATIONAL MEETING OF THE MILAN CENTER (NEUROMI) MILAN, JULY 6-8, 2016 FOR NEUROSCIENCE
www.neuromi.it SECOND INTERNATIONAL MEETING OF THE MILAN CENTER FOR NEUROSCIENCE (NEUROMI) PREDICTION AND PREVENTION OF DEMENTIA: NEW HOPE MILAN, JULY 6-8, 2016 Consiglio Nazionale delle Ricerche A new
The Genetic Basis of Neurological Disorders
The Genetic Basis of Neurological Disorders A complete advanced undergraduate/graduate course with: 22 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
CONTRASTS IN PHARMACOLOGY 2.0
CONTRASTS IN PHARMACOLOGY 2.0 Turin (Italy), May 14-16, 2015 Organized by DIPARTIMENTO DI SCIENZE DEL FARMACO UNIVERSITY OF PIEMONTE ORIENTALE Promoted by PRELIMINARY PROGRAM (Via Nino Costa, 8) Under
Magnetic Resonance Techniques in Multiple Sclerosis
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita - Salute San Raffaele University
ACADEMY MASS SPECTROMETRIC METHODS IN CLINICAL DIAGNOSIS PROGRAM CATANIA 20 JUNE 2008. One Day meeting on: CADEMY
Gruppo Interdivisionale di Chimica del Proteoma Under the auspices of One Day meeting on: MASS SPECTROMETRIC METHODS IN CLINICAL DIAGNOSIS PROGRAM CATANIA 20 JUNE 2008 Auditorium SIFI Via Ercole Patti,
November 5-6, 2015 Sala Napoleonica, Università degli Studi di Milano Via S. Antonio 10, Milano, Italia
Invited Speakers Yasmin Hurd PierVincenzo Piazza Tiziana Rubino Robin Murray Fabio Fumagalli Manuel Mameli Moshe Szyf Ronald See Sinha Raijta Daniela Braida Toni P George Marilyn Huestis November 5-6,
Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy
Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari
NEUROSCIENCE It s All in Your Head
NEUROSCIENCE It s All in Your Head The Institute for Neurological Discoveries Peter G. Smith, PhD, Director Why Neuroscience? One in 3 Americans will suffer from a major neurological disorder. The older
Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008
33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:
Programa Cooperación Farma-Biotech Neurociencias NT-KO-003
Programa Cooperación Farma-Biotech Neurociencias NT-KO-003 A new oral treatment for Multiple Sclerosis based on a novel mechanism of action Barcelona, 15 de febrero 2011 Programa Cooperación Farma-Biotech
Aging and Chronic Diseases
INTERNATIONAL SYMPOSIUM ON Aging and Chronic Diseases Intervention Strategies for a Successful Aging L Aquila (Italy) September 3 rd -5 th, 2015 Promoted by INTERNATIONAL SYMPOSIUM ON Geriatric Unit Department
1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)
UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:
European Educational Programme in Epidemiology
European Educational Programme in Epidemiology 29 th RESIDENTIAL SUMMER COURSE FLORENCE, ITALY Pre-courses 13 17 JUNE 2016 1/13 European Educational Programme in Epidemiology Pre-Course: Introduction to
Mediterranean School of Oncology
Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus
How To Teach Synthetic Biology
SSBSS 2015 Preliminary Program Supporters of SSBSS 2015 The organizers would like to acknowledge the following for their generous support of this summer school: Leonardo Design Systems 2 International
AMPYRA (dalfampridine) Important Safety Information
NEWS RELEASE Acorda to Present New rhigm22 and AMPYRA (dalfampridine) Data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 10/7/2015 ARDSLEY, N.Y.--(BUSINESS
Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS
Preliminary Programme INTERNATIONAL CONFERENCE Promoted by: Consiglio Nazionale delle Ricerche In collaboration with Stem cells: the diverging goals of regenerative medicine and oncology CHAIRMEN: KENNETH
International University of Monaco 27/04/2012 14:55 - Page 1. Monday 30/04 Tuesday 01/05 Wednesday 02/05 Thursday 03/05 Friday 04/05 Saturday 05/05
International University of Monaco 27/04/12 14:55 - Page 1 Master in International Business and Global Affairs - from 30 avril to 05 mai 12 Monday 30/04 Tuesday 01/05 Wednesday 02/05 Thursday 03/05 Friday
International University of Monaco 21/05/2012 16:01 - Page 1. Monday 30/04 Tuesday 01/05 Wednesday 02/05 Thursday 03/05 Friday 04/05 Saturday 05/05
International University of Monaco 21/05/12 16:01 - Page 1 Master in International Sport Business and Management - from 30 avril to 05 mai 12 Monday 30/04 Tuesday 01/05 Wednesday 02/05 Thursday 03/05 Friday
Heather M. Snyder Ph.D. heathersnyder1@me.com
Heather M. Snyder Ph.D. heathersnyder1@me.com Executive Director in Clinical Research and Development Central Nervous System Seasoned clinical researcher with over 20 years of experience in psychiatric,
The Management. 15 th December, VENICE Hotel Palazzo Giovanelli Santa Croce, San Stae, 2070. Workshop on
INTERNATIONAL CLUB OF ASCITES Workshop on The Management of Renal Dysfunction in Patients with Cirrhosis 14 th December, PADUA Aula Morgagni Policlinico Universitario Via Giustiniani 2 15 th December,
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
OHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
DENTAL HYGIENE RESEARCH MEETING
DENTAL HYGIENE RESEARCH MEETING Non Surgical Periodontal Treatment: How to Conciliate Scientific Evidences and Clinical Practice Pisa, December 14th -15th 2012 The event is accredited for n 4,5 ECM credits
Milan, Italy - 24-25 October 2013
PRELIMINARY PROGRAMME Preceptorship on MRI in multiple sclerosis Milan, Italy - 24-25 October 2013 Aim of the course The goal of this activity is to educate physicians regarding the application and the
www.iproteos.com Corporate Presentation November, 2013
www.iproteos.com Corporate Presentation November, 2013 The company Iproteos is an early-stage drug development company founded in 2011: Spin-Out from Institute for Research in Biomedicine (IRB Barcelona)
CCM National Project PRECIOUS Care of patients with acquired severe brain injury in Italy. In collaboration with
CCM National Project PRECIOUS Care of patients with acquired severe brain injury in Italy In collaboration with International workshop on Pathways of cure and care of patients in Vegetative State and Minimally
GE Global Research. The Future of Brain Health
GE Global Research The Future of Brain Health mission statement We will know the brain as well as we know the body. Future generations won t have to face Alzheimer s, TBI and other neurological diseases.
I Module Crime Scene & Forensic Genetics
I Module Crime Scene & Forensic Genetics Is a 2 week academic summer programme giving students the opportunity to participate in seminars and tutorials to learn more about criminal investigations. The
AOSpine Masters Symposium Adult deformity of the cervical, thoracic and lumbar spine
EUROPE Event program AOSpine Masters Symposium Adult deformity of the cervical, thoracic and lumbar spine June 13 14, 2014 Florence, Italy June 13 14, 2014 Florence, Italy 3 Dear AOSpine Participant On
BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C
Symposium of the Swiss-Austrian ISOP Chapter International Society of Pharmacovigilance BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Program: Thursday,
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective May 11 12; 2015 Hotel Hesselet, Nyborg Symposium organizers Morten Blinkenberg, University of
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Proposed Health Technology Appraisal Daclizumab for treating relapsing-remitting multiple Draft scope (pre-referral) Draft remit/appraisal objective To
DRUG ADDICTION: from basic science to clinical management
DRUG ADDICTION: from basic science to clinical management Busto Arsizio, September 26 th -28 th 2012 DiSTA, Biomedical Research Division, University of Insubria Course Directors: Daniela Parolaro Giorgio
Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast
Scientifically Minded. Medically Driven.
Scientifically Minded. Medically Driven. MEDICALLY DRIVEN. 01 SCIENTIFICALLY MINDED. At Worldwide Clinical Trials we strategically balance science, medicine, operations and commercial intelligence to achieve
on End Stage Focus on Idiopathic
II International Conference on End Stage Lung DiseaseS: Focus on Idiopathic Pulmonary Fibrosis Padua - Italy, February 22 nd, 2013 Palazzo del Bo - Aula Nievo ENDORSEMENTS WELCOME TO PADUA Italian Association
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
Jornada Informativa en Bioeconomía. Retos Colaboración 2016
Jornada Informativa en Bioeconomía. Retos Colaboración 2016 Novel Multifunctional Nanoplatform as Theranostic Technology for the Alzheimer Disease. NANOTHERAD autor: María del Carmen Dona MD PhD PROPOSAL:
Elective Options for MS in Clinical and Translational Sciences Program
Elective Options for MS in Clinical and Translational Sciences Program NOTE: ALL ELECTIVES MUST BE GRADUATE LEVEL COURSES AND APPROVED BY A MS CTS PROGRAM DIRECTOR IN ORDER TO RECEIVE CREDIT TOWARDS MCTS
Calendar of events NEUROLOGY
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC
Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC Committee on Oversight and Government Reform Domestic Policy Subcommittee U.S. House of
ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS
ADULT HEALTH AND WELLBEING LONG-TERM NEUROLOGICAL CONDITIONS i. Summary The National Service Framework for long-term neurological conditions categorises neurological conditions as: Sudden-onset conditions
Università Politecnica delle Marche
6 th Edition of the: UNIVPM - UNIDO E-Biosafety Master Summer ON CAMPUS SCUOLA DI DOTTORATO DELLA FACOLTA DI AGRARIA Ancona, June 17 21, 2013 Programme June 16, 2013 Arrival to Ancona Monday 17, June 2013-ROOM
BSc in Medical Sciences with PHARMACOLOGY
BSc in Medical Sciences with PHARMACOLOGY Course Director Dr Christopher John Module Leaders Dr Robert Dickinson (Module 1) Dr Anabel Varela Carver (Module 2) Dr Sohag Saleh (Module 3) Course Administrator
How To Become A Biobanker
IV ESBB Annual Meetin Leipzig, October, 201 Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network Biobanker Where biobankers comes from We need to prepare a new
Trading Calendar - East Capital UCITS Funds
Trading Calendar - UCITS s The table shows i) the days the funds will be closed due to holidays and ii) which days the funds have early cut-off times (11.30am Central European Time). Please note that the
Increasing Innovation in R&D - Seizing early stage external growth opportunities
Increasing Innovation in R&D - Seizing early stage external growth opportunities Paul R. Eynott, PhD sanofi-aventis, US paul.eynott@sanofi-aventis.com -1- Sommaire -2- CHRISTOPHER A. VIEHBACHER Chief Executive
Genomics in Hematology
Università degli Studi di Perugia Genomics in Hematology January 29-31, 2012 Perugia Camera di Commercio Congress Center January 29 th, 2012 Opening Session Teatro del Pavone Chairs: Franco Aversa, Cristina
Pharmacology skills for drug discovery. Why is pharmacology important?
skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th
2012 Global Neuro-psychiatric Devices New Product Innovation Award
2012 Global Neuro-psychiatric Devices New Product Innovation Award Frost & Sullivan s Global Research Platform Frost & Sullivan has over 50 years of expertise in business with a global research organization
Treating Multiple Sclerosis and many other conditions YOUR LIFE, YOUR CHOICE, YOUR CENTRE.
Treating Multiple Sclerosis and many other conditions YOUR LIFE, YOUR CHOICE, YOUR CENTRE. Welcome to the West of England MS Therapy Centre WE OFFER Physiotherapy, Oxygen Treatment, Counselling/Life Coaching,
MedTASS 2013 12-13 3 MEDITERRANEAN TRANSPLANTATION ANESTHESIOLOGY AND SIMULATION SYMPOSIUM. Villa Igiea - PALERMO. April 2013.
MedTASS 2013 rd 3 MEDITERRANEAN TRANSPLANTATION ANESTHESIOLOGY Villa Igiea - PALERMO th th 12-13 April 2013 1 MedTASS 2013 MedTASS 2013 Dear colleagues, It is our honor and privilege to invite you to the
o Emergency W o UNDS R JOIN NOW! FIRST INTERNATIONAL MEDICAL SEMINAR ISRAEL - ITALY ON EMERGENCIES AND MASS CASUALTY INCIDENTS
A I D o Emergency FIRST INTERNATIONAL MEDICAL SEMINAR ISRAEL - ITALY ON EMERGENCIES AND MASS CASUALTY INCIDENTS In the picturesque scenery of a medieval town amongst the mountains, A.S.L. CN1 invites you
Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA.
Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA June 25-26, 2013 University Campus Salvatore Venuta,Catanzaro,Italy Building H,
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
31st Annual Update for the Comprehensive Ophthalmologist 2013
Presented By: Sponsored By: 31st Annual Update for the Comprehensive Ophthalmologist 2013 Edward W. Purnell, M.D. Distinguished Lectureship Douglas A. Jabs, M.D., M.B.A. Professor and Chair of the CEO
CRS workshop 21 st -23 rd November 2013
Organizing committee: Prof. Pietro Matricardi Prof. Ida Genta Dr. Rossella Dorati Dr. Barbara Colzani Dr. Giuseppe Tripodo Scientific committee: Prof. Paolo Caliceti Prof. Bice Conti Prof. Elias Fattal
Alberta/Novartis Translational Research Fund Opportunity. Program Guide 2014/2015
OBJECTIVES Program Guide 2014/2015 Alberta Innovates - Health Solutions (AIHS), Novartis Pharmaceuticals Canada Inc. (Novartis), and the Government of Alberta have partnered to create the Alberta/Novartis
Clinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved
Clinical and Therapeutic Cannabis Information Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 Chronic Pain... 6 Neuropathic Pain... 8 Movement Disorders...